foxo4-dri senolytic human trial 2024 Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Targeting Cellular Senescence in Aging
Description
The viable cells were quantified by the reaction with MTT
Touch device users, explore by touch or with swipe gestures
Lot's of tests at the hospital to no avail
Currently, this drug is widely used for the clinical treatment of several cancers
